Free Trial

Centessa Pharmaceuticals (CNTA) SEC Filings & 10K Form

Centessa Pharmaceuticals logo
$15.80 -0.43 (-2.65%)
Closing price 03/10/2025 04:00 PM Eastern
Extended Trading
$15.81 +0.01 (+0.06%)
As of 03/10/2025 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Centessa Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/20/2025
4:45 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:59 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:33 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:14 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:55 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:55 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:55 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:57 PM
Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:57 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:08 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
3:04 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
3:32 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:07 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
3:16 PM
Centessa Pharmaceuticals (Issuer)
Kanes Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
6:00 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:30 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:31 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:33 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
4:28 PM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
5:10 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:22 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:18 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
4:09 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:10 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:11 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:02 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:14 PM
Centessa Pharmaceuticals (Subject)
HUSSAIN IQBAL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:03 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:14 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:03 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:07 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
4:06 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:33 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:43 PM
Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The real reason gold is soaring (and likely to continue) (Ad)

Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett’s insights show you how to position yourself for wealth in 2025. Don’t wait—these opportunities can disappear fast!

Discover Garrett’s highly sought-after gold insights and seize this opportunity before it’s gone.
11/12/2024
6:16 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
6:19 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:10 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:27 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:07 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:15 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
3:01 PM
Centessa Pharmaceuticals (Filer)
Form 10-Q/A
09/27/2024
3:15 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:01 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:55 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:01 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:01 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:40 PM
Centessa Pharmaceuticals (Filer)
Form 424B5
09/11/2024
3:01 PM
Centessa Pharmaceuticals (Filer)
Form S-3ASR
09/10/2024
3:04 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:06 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:06 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:12 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:13 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:19 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
4:15 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:32 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:13 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:38 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:52 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
6:27 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:15 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:31 PM
Bush Tia L (Reporting)
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:31 PM
Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:33 PM
Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:34 PM
Centessa Pharmaceuticals (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:34 PM
Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:14 PM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:49 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/10/2024
6:13 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
7:48 PM
Centessa Pharmaceuticals (Filer)
Form DEFA14A
05/13/2024
3:32 PM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:00 AM
Centessa Pharmaceuticals (Filer)
Form DEF 14A
05/09/2024
7:01 AM
Centessa Pharmaceuticals (Filer)
Form ARS
04/24/2024
7:53 PM
Centessa Pharmaceuticals (Filer)
Form 424B5
04/24/2024
8:26 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
4:16 PM
Centessa Pharmaceuticals (Filer)
Form 424B5
04/22/2024
6:15 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:17 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:15 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Your Wealth is Under Attack (Ad)

Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.

Click here now to see how to stop them in their tracks!
04/02/2024
3:16 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:44 PM
Centessa Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
3:16 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:06 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CNTA) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners